CLINICAL_TRIALS
ClinicalTrials.gov record update
Open-Label Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of BHV-0223 in Subjects With Amyotrophic Lateral Sclerosis
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03520517
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:58.049220+00:00
- Published At
- 2022-10-06T00:00:00+00:00
- Record Updated At
- 2022-10-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Amyotrophic Lateral Sclerosis", "ALS", "Lou Gehrig Disease", "Lou Gehrig\u0027s Disease", "Lou-Gehrigs Disease", "Motor Neuron Disease, Amyotrophic Lateral Sclerosis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-10-06"- protocolSection.identificationModule.nctId
"NCT03520517"- protocolSection.identificationModule.officialTitle
"Open-Label Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of BHV-0223 in Subjects With Amyotrophic Lateral Sclerosis"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.